Sexual Dysfunction as it Intersects with Neurogenic Lower Urinary Tract Dysfunction in Women

Abstract Purpose of Review This review explores the relationship between sexual dysfunction (SD) and neurogenic lower urinary tract dysfunction (NLUTD) in women, focusing on diagnostic challenges, evaluation methods, and treatment strategies. Recent Findings SD in women with NLUTD is multifactorial, influenced by medical comorbidities and psychosocial factors. Advances in hormonal therapies, pharmacologic agents, and treatments for concomitant urinary incontinence (chemodenervation and neurostimulation) show promise for treatment. However, gaps remain in validated screening tools, physician training, and standardized treatment protocols, creating barriers to care. Summary Managing SD in women with NLUTD requires a multidisciplinary approach. While current treatments demonstrate potential, standardized guidelines and evidence-based screening tools are lacking. Future efforts should focus on developing universal protocols and innovative therapies to improve quality of life and clinical outcomes.